CorMedix Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.32 | -$0.23 | -$0.28 |
| Q2 2024 | 0 | -$0.29 | -$0.21 | -$0.25 |
| Q3 2024 | 2 | -$0.14 | -$0.10 | -$0.12 |
| Q4 2024 | 0 | -$0.02 | -$0.02 | -$0.02 |
| Q1 2025 | 1 | $0.01 | $0.01 | $0.01 |
| Q2 2025 | 1 | $0.02 | $0.03 | $0.03 |
| Q3 2025 | 1 | $0.04 | $0.06 | $0.05 |
| Q4 2025 | 1 | $0.07 | $0.09 | $0.08 |
CorMedix Inc. Earnings Date And Information
CorMedix Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.25 earnings per share for the quarter, topping analysts' consensus estimates of $-0.26 by $0.01. The company had revenue of 806,119 for the quarter and had revenue of 0 for the year. CorMedix Inc. has generated $-1 earnings per share over the last year ($-0.91 diluted earnings per share) and currently has a price-to-earnings ratio of -8.73. CorMedix Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
CorMedix Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.26 | -$0.25 | 0.01 | $1.67 M | $806,119 |
| 05/09/2024 | Q1 2024 | -$0.27 | -$0.25 | 0.02 | $0 | |
| 03/12/2024 | Q4 2023 | -$0.21 | -$0.26 | -0.05 | $304,110 | |
| 11/14/2023 | Q3 2023 | -$0.21 | -$0.17 | 0.04 | $0 | $0 |
| 08/08/2023 | Q2 2023 | -$0.22 | -$0.25 | -0.03 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.20 | $9.78 | 9.98 | $0 | |
| 03/30/2023 | Q4 2022 | -$0.19 | -$0.19 | 0 | $29,702 | |
| 11/10/2022 | Q3 2022 | -$0.23 | -$0.17 | 0.06 | $25,299 | $6,817 |
| 08/11/2022 | Q2 2022 | -$0.20 | -$0.19 | 0.01 | $21,253 | |
| 05/12/2022 | Q1 2022 | -$0.23 | -$0.18 | 0.05 | $7,636 | |
| 03/29/2022 | Q4 2021 | -$0.22 | -$0.21 | 0.01 | $56,397 | |
| 11/09/2021 | Q3 2021 | -$0.18 | -$0.22 | -0.04 | $20,000 | $38,088 |
| 08/12/2021 | Q2 2021 | -$0.18 | -$0.12 | 0.06 | $43,250 | $8,191 |
| 05/13/2021 | Q1 2021 | -$0.18 | -$0.20 | -0.02 | $88,261 | |
| 03/30/2021 | Q4 2020 | -$0.23 | -$0.19 | 0.04 | $55,713 | |
| 11/05/2020 | Q3 2020 | -$0.26 | -$0.22 | 0.04 | $28,750 | $93,020 |
| 08/10/2020 | Q2 2020 | -$0.24 | -$0.14 | 0.1 | $117,500 | $16,443 |
| 05/11/2020 | Q1 2020 | -$0.23 | -$0.21 | 0.02 | $74,054 | |
| 03/16/2020 | Q4 2019 | -$0.24 | -$0.21 | 0.03 | $24,779 | |
| 11/14/2019 | Q3 2019 | -$0.25 | -$0.22 | 0.03 | $80,000 | $59,530 |
CorMedix Inc. Earnings: Frequently Asked Questions
-
When is CorMedix Inc.'s earnings date?
CorMedix Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
Did CorMedix Inc. beat their earnings estimates last quarter?
In the previous quarter, CorMedix Inc. (:CRMD) reported $-0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.26 by $0.01.
-
How can I listen to CorMedix Inc.'s earnings conference call?
The conference call for CorMedix Inc.'s latest earnings report can be listened to online.
-
How can I read CorMedix Inc.'s conference call transcript?
The conference call transcript for CorMedix Inc.'s latest earnings report can be read online.
-
How much profit does CorMedix Inc. generate each year?
CorMedix Inc. (:CRMD) has a recorded net income of $0. CorMedix Inc. has generated $-0.91 earnings per share over the last four quarters.
-
What is CorMedix Inc.'s price-to-earnings ratio?
CorMedix Inc. (:CRMD) has a price-to-earnings ratio of -8.73 and price/earnings-to-growth ratio is 0.38.
